Adjustment of a Cellular Based Methodology to Predict Response to Melphalan - Oxaliplatin in Breast and Colon Cancer
- Veröffentlicht:19. Mai 2011
- Dashboard:33rd Conference EEBE – Adjustment of a Cellular Based Methodology to Predict Response to Melphalan - Oxaliplatin in Breast and Colon Cancer
- Autoren:Apostolou P., Toloudi M., Chatziioannou M., Papasotiriou I.
Erfahren Sie mehr über die wissenschaftliche Grundlage der Tests von RGCC